Suppr超能文献

在成年雄性大鼠体内,西咪替丁可抑制肝脏中的CYP2C6和CYP2C11,但不抑制CYP1A1。

In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.

作者信息

Levine M, Law E Y, Bandiera S M, Chang T K, Bellward G D

机构信息

Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

J Pharmacol Exp Ther. 1998 Feb;284(2):493-9.

PMID:9454789
Abstract

We previously reported that in vivo cimetidine inhibits hepatic microsomal enzyme activities mediated by cytochrome P450 (CYP)2C11 and at least one other CYP enzyme but does not inhibit CYP2A1-, CYP2B- or CYP3A-mediated activities in adult male rats. To investigate the effects of in vivo cimetidine on CYP1A1, cimetidine (150 mg/kg i.p.) or saline was administered to beta-naphthoflavone-induced (40 mg/kg i.p. once daily for 3 consecutive days) or uninduced adult male Wistar rats, and hepatic microsomes were prepared 90 min after the cimetidine injection. Cimetidine had no effect on either methoxyresorufin O-dealkylase (MROD) or ethoxyresorufin O-dealkylase (EROD) activity in microsomes from beta-naphthoflavone-induced rats. In these same microsomes, polyclonal anti-CYP1A1 IgG inhibited both MROD and EROD activities by >90%, whereas monoclonal anti-CYP1A1 IgG inhibited MROD and EROD activities by 60% and 80%, respectively. In contrast, cimetidine inhibited MROD and EROD activities in microsomes from uninduced rats by 50% and 65%, respectively (P < .05). Immunoinhibition studies with polyspecific and monospecific anti-CYP2C11 IgG indicated that MROD and EROD activities are mediated by a CYP2C enzyme or enzymes other than CYP2C11 in these microsomes. To investigate the possibility that the drug affected EROD activity in uninduced rats by inhibiting CYP2C6, cimetidine was administered as described to rats that had been pretreated with phenobarbital (80 mg/kg i.p once daily for 4 consecutive days). In hepatic microsomes from these rats, cimetidine inhibited progesterone 21-hydroxylase activity (mediated by CYP2C6) by 62% and progesterone 2alpha-hydroxylase activity (mediated by CYP2C11) by 39% but had no effect on progesterone 6beta-hydroxylase activity (mediated by CYP3A). Taken together, the results indicate that in vivo cimetidine has no effect on CYP1A1 but inhibits CYP2C6 in addition to CYP2C11. Preincubation of microsomes from uninduced rats with cimetidine and NADPH in vitro increased the potency of inhibition of EROD activity by 20-fold, suggesting that cimetidine inhibits CYP2C6, as it does CYP2C11: by forming a metabolite/intermediate complex.

摘要

我们之前报道过,在成年雄性大鼠体内,西咪替丁可抑制细胞色素P450(CYP)2C11介导的肝微粒体酶活性以及至少一种其他CYP酶的活性,但不抑制CYP2A1、CYP2B或CYP3A介导的活性。为了研究体内西咪替丁对CYP1A1的影响,将西咪替丁(150mg/kg腹腔注射)或生理盐水给予经β-萘黄酮诱导(40mg/kg腹腔注射,连续3天,每日1次)或未经诱导的成年雄性Wistar大鼠,并在注射西咪替丁90分钟后制备肝微粒体。西咪替丁对β-萘黄酮诱导的大鼠微粒体中的甲氧基试卤灵O-脱烷基酶(MROD)或乙氧基试卤灵O-脱烷基酶(EROD)活性均无影响。在这些相同的微粒体中,多克隆抗CYP1A1 IgG可使MROD和EROD活性均受到>90%的抑制,而单克隆抗CYP1A1 IgG分别使MROD和EROD活性受到60%和80%的抑制。相比之下,西咪替丁分别使未经诱导的大鼠微粒体中的MROD和EROD活性受到50%和65%的抑制(P<.05)。用多特异性和单特异性抗CYP2C11 IgG进行的免疫抑制研究表明,这些微粒体中的MROD和EROD活性是由CYP2C11以外的一种或多种CYP2C酶介导的。为了研究该药物是否通过抑制CYP2C6影响未经诱导的大鼠体内的EROD活性,按照上述方法将西咪替丁给予用苯巴比妥预处理过的大鼠(80mg/kg腹腔注射,连续4天,每日1次)。在这些大鼠的肝微粒体中,西咪替丁使孕酮21-羟化酶活性(由CYP2C6介导)受到62%的抑制,使孕酮2α-羟化酶活性(由CYP2C11介导)受到39%的抑制,但对孕酮6β-羟化酶活性(由CYP3A介导)无影响。综上所述,结果表明体内西咪替丁对CYP1A1无影响,但除了CYP2C11外还抑制CYP2C6。将未经诱导的大鼠的微粒体与西咪替丁和NADPH在体外预孵育可使EROD活性的抑制效力提高20倍,这表明西咪替丁抑制CYP2C6的方式与抑制CYP2C11相同:通过形成代谢物/中间体复合物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验